Clinical trials
Cholangiocarcinoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 7 |
| 2018 | 2 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 7 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 13 |
| Active, not recruiting | 9 |
| Recruiting | 9 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| Taiho Oncology, Inc. | 3 |
| AbbVie | 2 |
| EMD Serono Research & Development Institute, Inc. | 2 |
| Hoffmann-La Roche | 2 |
| Incyte Corporation | 2 |
| Merck Sharp & Dohme LLC | 2 |
| QED Therapeutics, a BridgeBio company | 2 |
| Alentis Therapeutics AG | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 50 |
| Ovarian Neoplasms | 9 |
| Triple Negative Breast Neoplasms | 9 |
| Bile Duct Neoplasms | 8 |
| Biliary Tract Neoplasms | 8 |
| Carcinoma, Hepatocellular | 8 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Gallbladder Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
| Colorectal Neoplasms | 6 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.